Brokerages expect that Omega Healthcare Investors Inc (NYSE:OHI) will report sales of $228.31 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Omega Healthcare Investors’ earnings, with the lowest sales estimate coming in at $220.08 million and the highest estimate coming in at $233.70 million. Omega Healthcare Investors posted sales of $219.88 million in the same quarter last year, which suggests a positive year-over-year growth rate of 3.8%. The company is scheduled to announce its next quarterly earnings results on Friday, August 2nd.
According to Zacks, analysts expect that Omega Healthcare Investors will report full year sales of $919.97 million for the current year, with estimates ranging from $878.98 million to $950.59 million. For the next year, analysts anticipate that the firm will post sales of $981.54 million, with estimates ranging from $898.75 million to $1.05 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that cover Omega Healthcare Investors.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.34 EPS for the quarter, missing the Zacks’ consensus estimate of $0.71 by ($0.37). Omega Healthcare Investors had a return on equity of 7.02% and a net margin of 30.17%. The company had revenue of $188.20 million for the quarter, compared to the consensus estimate of $190.54 million. During the same period last year, the firm earned $0.78 earnings per share. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year.
A number of research firms have commented on OHI. ValuEngine raised shares of Yelp from a “sell” rating to a “hold” rating in a research report on Wednesday, April 3rd. Zacks Investment Research cut shares of Haynes International from a “hold” rating to a “sell” rating in a research report on Wednesday, May 8th. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $37.05.
In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $37.00, for a total transaction of $370,000.00. Following the transaction, the chief financial officer now owns 233,326 shares in the company, valued at approximately $8,633,062. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO C Taylor Pickett sold 30,000 shares of the stock in a transaction on Monday, June 24th. The stock was sold at an average price of $38.00, for a total value of $1,140,000.00. Following the transaction, the chief executive officer now owns 269,133 shares in the company, valued at approximately $10,227,054. The disclosure for this sale can be found here. Insiders have sold a total of 85,500 shares of company stock worth $3,239,000 in the last quarter. Company insiders own 1.16% of the company’s stock.
A number of hedge funds have recently bought and sold shares of OHI. BlackRock Inc. increased its position in shares of Omega Healthcare Investors by 2.7% in the first quarter. BlackRock Inc. now owns 24,307,257 shares of the real estate investment trust’s stock worth $927,322,000 after purchasing an additional 629,799 shares during the period. Federated Investors Inc. PA increased its position in shares of Omega Healthcare Investors by 7.6% in the first quarter. Federated Investors Inc. PA now owns 3,460,637 shares of the real estate investment trust’s stock worth $132,023,000 after purchasing an additional 243,272 shares during the period. Geode Capital Management LLC increased its position in shares of Omega Healthcare Investors by 8.0% in the fourth quarter. Geode Capital Management LLC now owns 2,312,184 shares of the real estate investment trust’s stock worth $81,791,000 after purchasing an additional 171,333 shares during the period. Two Sigma Investments LP increased its position in shares of Omega Healthcare Investors by 61,976.7% in the fourth quarter. Two Sigma Investments LP now owns 1,339,615 shares of the real estate investment trust’s stock worth $47,087,000 after purchasing an additional 1,337,457 shares during the period. Finally, Norges Bank bought a new position in shares of Omega Healthcare Investors in the fourth quarter worth $46,751,000. Hedge funds and other institutional investors own 69.29% of the company’s stock.
OHI stock opened at $36.96 on Thursday. The company has a debt-to-equity ratio of 1.16, a quick ratio of 2.86 and a current ratio of 2.86. The stock’s fifty day moving average is $36.78. Omega Healthcare Investors has a one year low of $28.65 and a one year high of $40.30. The company has a market capitalization of $7.65 billion, a PE ratio of 12.16, a price-to-earnings-growth ratio of 4.85 and a beta of 0.42.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Investing in Growth Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.